Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Extraordinary professor appointed
2005-11-10

UFS appoints its first extraordinary professor for health systems research and development  

 

 

Prof Dingie van Rensburg (Director: Centre for Health Systems Research and Development at the UFS) and Prof  Helen Schneider (senior researcher at the University of the Witwatersrand's Centre for Health Policy and extraordinary professor at the UFS Centre for Health Systems Research and Development). Photo: L Loader

 

The Centre for Health Systems Research and Development (CHSR&D) at the University of the Free State (UFS) has appointed its first extraordinary professor. 

Prof Helen Schneider, former director of the Centre for Health Policy at the University of the Witwatersrand (WITS) and currently senior researcher in that Centre and consultant in the WITS School of Public Health, was appointed by CHSR&D for a period of two years.

“Prof Schneider is widely known for her thorough experience, expertise and exposure in the field of public health, health policy and management and health policy and systems research.  We are honoured to have her join us as an extraordinary professor,”  said Prof Dingie van Rensburg, Director of CHSR&D.

Prof Schneider will be involved in various components of the CHSR&D’s long-term project on public sector anti-retroviral treatment (ART) and will also assist in the documenting, monitoring, evaluating and facilitation of the implementation of the national treatment plan in the Free State.  She is also assisting the Gauteng Department of Health in a similar way.

“The two provinces are actually so different.  They provide a different window on the realities of HIV/AIDS and the intellectual traditions involved in it,” said Prof Schneider.  “I hope to contribute meaningfully to finding new dimensions for research necessary in order to optimise the contribution and effect of the research on ART,” said Prof Schneider.

Another need for Prof Schneider’s appointment is to strengthen the senior research capacity of the CHSR&D, guide them with the ART project and assist in the implementation of research results into policy, management and practice.

Media release
Issued by:Lacea Loader
Media Representative
Tel:  (051) 401-2584
Cell:  083 645 2454
E-mail:  loaderl.stg@mail.uovs.ac.za
9 November 2005

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept